Medscape September 16, 2024
MADRID — In spirited presentations at the European Association for the Study of Diabetes (EASD) 2024 Annual Meeting, Louis J. Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity medications will make bariatric surgery obsolete, and Francesco Rubino, MD, of King’s College London, London, England, made an equally compelling case that they will not.
In fact, Rubino predicted that “metabolic” surgery — new nomenclature reflecting the power of surgery to reduce not only obesity, but also other metabolic conditions, over the long term — will continue and could even increase in years to come.
‘Medical Treatment Will Dominate’
“Obesity treatment is the superhero of treating metabolic disease because it...
Today's Sponsors
Today's Sponsor